Mimedx (MDXG) EBT Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -29.12% |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 26.74% |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 35.87% |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 53.94% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 12.65% |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 29.89% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -123.12% |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 31.69% |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 17.94% |
| 10 | Mimedx | 676.17 Mn | 540.33 Mn | 44.38 Mn | -236.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -236.70% |
| Mar 31, 2026 | -278.02% |
| Dec 31, 2025 | 93.75% |
| Sep 30, 2025 | 100.10% |
| Jun 30, 2025 | -43.97% |
| Mar 31, 2025 | -24.52% |
| Dec 31, 2024 | -19.15% |
| Sep 30, 2024 | 21.05% |
| Jun 30, 2024 | 152.98% |
| Mar 31, 2024 | 703.33% |
| Dec 31, 2023 | 41.13% |
| Sep 30, 2023 | 212.66% |
| Jun 30, 2023 | 184.93% |
| Mar 31, 2023 | 81.86% |
| Dec 31, 2022 | 10,732.97% |
| Sep 30, 2022 | -310.84% |
| Jun 30, 2022 | -505.72% |
| Mar 31, 2022 | -25.25% |
| Dec 31, 2021 | 100.52% |
| Sep 30, 2021 | 89.48% |